Thu, 28 March 2013
Dr. Sarah Goldberg on the Utility of Molecular Marker Results in the Adjuvant Setting for Early Stage Non-Small Cell Lung Cancer
Dr. Sarah Goldberg addresses the question of whether to obtain molecular marker results in patients with early stage lung cancer and what to do with that information if it is available for potential application in the adjuvant setting.
Direct download: GRACEcastUC-067_Lung-Video_Goldberg_on_Targeted_Rx_Adjuvant.m4v
Category:Lung-Cancer-Video -- posted at: 6:11pm PDT